Suppr超能文献

HEF1/NEDD9/Cas-L作为侵袭、凋亡和细胞周期多功能协调因子发挥作用的分子基础。

Molecular basis for HEF1/NEDD9/Cas-L action as a multifunctional co-ordinator of invasion, apoptosis and cell cycle.

作者信息

Singh Mahendra, Cowell Lauren, Seo Sachiko, O'Neill Geraldine, Golemis Erica

机构信息

Division of Basic Science, Fox Chase Cancer Center, Philadelphia, PA 19111, USA.

出版信息

Cell Biochem Biophys. 2007;48(1):54-72. doi: 10.1007/s12013-007-0036-3.

Abstract

Upregulation of the scaffolding protein HEF1, also known as NEDD9 and Cas-L, has recently been identified as a pro-metastatic stimulus in a number of different solid tumors, and has also been strongly associated with pathogenesis of BCR-Abl-dependent tumors. As the evidence mounts for HEF1/NEDD9/Cas-L as a key player in metastatic cancer, it is timely to review the molecular regulation of HEF1/NEDD9/Cas-L. Most of the mortality associated with cancer arises from uncontrolled metastases, thus a better understanding of the properties of proteins specifically associated with promotion of this process may yield insights that improve cancer diagnosis and treatment. In this review, we summarize the extensive literature regarding HEF1/NEDD9/Cas-L expression and function in signaling relevant to cell attachment, migration, invasion, cell cycle, apoptosis, and oncogenic signal transduction. The complex function of HEF1/NEDD9/Cas-L revealed by this analysis leads us to propose a model in which alleviation of cell cycle checkpoints and acquired resistance to apoptosis is permissive for a HEF1/NEDD9/Cas-L-promoted pro-metastatic phenotype.

摘要

支架蛋白HEF1(也称为NEDD9和Cas-L)的上调最近被确定为多种不同实体瘤中的促转移刺激因素,并且还与BCR-Abl依赖性肿瘤的发病机制密切相关。随着越来越多的证据表明HEF1/NEDD9/Cas-L是转移性癌症的关键参与者,及时回顾HEF1/NEDD9/Cas-L的分子调控机制很有必要。大多数与癌症相关的死亡都源于不受控制的转移,因此更好地了解与促进这一过程特别相关的蛋白质特性,可能会为改善癌症诊断和治疗带来启示。在这篇综述中,我们总结了关于HEF1/NEDD9/Cas-L在与细胞附着、迁移、侵袭、细胞周期、凋亡和致癌信号转导相关的信号传导中的表达和功能的大量文献。通过该分析揭示的HEF1/NEDD9/Cas-L的复杂功能,使我们提出了一个模型,其中细胞周期检查点的缓解和对凋亡的获得性抗性允许HEF1/NEDD9/Cas-L促进的促转移表型。

相似文献

2
Preclinical and clinical studies of the NEDD9 scaffold protein in cancer and other diseases.
Gene. 2015 Aug 1;567(1):1-11. doi: 10.1016/j.gene.2015.04.086. Epub 2015 May 9.
4
A new central scaffold for metastasis: parsing HEF1/Cas-L/NEDD9.
Cancer Res. 2007 Oct 1;67(19):8975-9. doi: 10.1158/0008-5472.CAN-07-1328.
5
Crk-associated substrate lymphocyte type regulates myeloid cell motility and suppresses the progression of leukemia induced by p210Bcr/Abl.
Cancer Sci. 2011 Dec;102(12):2109-17. doi: 10.1111/j.1349-7006.2011.02066.x. Epub 2011 Sep 23.
6
Nedd9/Hef1/Cas-L mediates the effects of environmental pollutants on cell migration and plasticity.
Oncogene. 2009 Oct 15;28(41):3642-51. doi: 10.1038/onc.2009.224. Epub 2009 Aug 3.
7
Regulation of invasive behavior by vascular endothelial growth factor is HEF1-dependent.
Oncogene. 2010 Aug 5;29(31):4449-59. doi: 10.1038/onc.2010.185. Epub 2010 May 24.
8
NEDD9 is a positive regulator of epithelial-mesenchymal transition and promotes invasion in aggressive breast cancer.
PLoS One. 2011;6(7):e22666. doi: 10.1371/journal.pone.0022666. Epub 2011 Jul 28.
9
Dissection of HEF1-dependent functions in motility and transcriptional regulation.
J Cell Sci. 2002 Jan 1;115(Pt 1):99-111. doi: 10.1242/jcs.115.1.99.

引用本文的文献

2
Targeting NEDD9-SH3 with a Covalent Peptide Controls Endothelial Phenotype.
bioRxiv. 2025 Jul 12:2025.07.10.663547. doi: 10.1101/2025.07.10.663547.
3
The scaffold protein CasL restrains membrane blebbing and promotes T cell migration.
J Cell Sci. 2025 Jul 15;138(14). doi: 10.1242/jcs.263792. Epub 2025 Jul 18.
5
The Prognostic Significance of NEDD9 Expression in Human Cancers: A Systematic Review, Meta-Analysis, and Omics Exploration.
Technol Cancer Res Treat. 2024 Jan-Dec;23:15330338241297597. doi: 10.1177/15330338241297597.
6
CBF-Beta Mitigates PI3K-Alpha-Specific Inhibitor Killing through PIM1 in PIK3CA-Mutant Gastric Cancer.
Mol Cancer Res. 2023 Nov 1;21(11):1148-1162. doi: 10.1158/1541-7786.MCR-23-0034.
8
Silencing NEDD9 by lentivirus-delivered shRNA inhibits the growth of BxPC-3 cells and .
Transl Cancer Res. 2019 Sep;8(5):1873-1881. doi: 10.21037/tcr.2019.09.02.
9
NEDD9 overexpression: Prognostic and guidance value in acute myeloid leukaemia.
J Cell Mol Med. 2021 Oct;25(19):9331-9339. doi: 10.1111/jcmm.16870. Epub 2021 Aug 25.
10
Susceptibility-Associated Genetic Variation in Contributes to Prostate Cancer Initiation and Progression.
Cancer Res. 2021 Jul 15;81(14):3766-3776. doi: 10.1158/0008-5472.CAN-20-3042. Epub 2021 Feb 25.

本文引用的文献

1
Structure and function of cas-L and integrin-mediated signaling.
Crit Rev Immunol. 2006;26(5):391-406. doi: 10.1615/critrevimmunol.v26.i5.20.
2
Differential transmission of actin motion within focal adhesions.
Science. 2007 Jan 5;315(5808):111-5. doi: 10.1126/science.1135085.
4
Force sensing by mechanical extension of the Src family kinase substrate p130Cas.
Cell. 2006 Dec 1;127(5):1015-26. doi: 10.1016/j.cell.2006.09.044.
5
Interdependence of cell attachment and cell cycle signaling.
Curr Opin Cell Biol. 2006 Oct;18(5):507-15. doi: 10.1016/j.ceb.2006.08.014. Epub 2006 Aug 17.
6
7
Comparative oncogenomics identifies NEDD9 as a melanoma metastasis gene.
Cell. 2006 Jun 30;125(7):1269-81. doi: 10.1016/j.cell.2006.06.008.
8
Characterization of AND-34 function and signaling.
Methods Enzymol. 2006;407:55-63. doi: 10.1016/S0076-6879(05)07006-0.
9
RanBPM contributes to Semaphorin3A signaling through plexin-A receptors.
J Neurosci. 2006 May 3;26(18):4961-9. doi: 10.1523/JNEUROSCI.0704-06.2006.
10
Fibronectin rigidity response through Fyn and p130Cas recruitment to the leading edge.
Mol Biol Cell. 2006 Jun;17(6):2684-95. doi: 10.1091/mbc.e05-12-1161. Epub 2006 Apr 5.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验